MPDA@Fe3O4‐Era plus laser irradiation indicates a highly effective tumor suppression, which raises •OH level, inactivates GPX4, improves small molecule Era bioavailability for potent system xc− inhibition and promotes the development of precise synergistic tumor therapy. The gene discussed is GPX4; the disease is neoplasm.